Skip to content

Author

L. Jackson

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Development of a clinical-grade ultrasensitive droplet digital PCR test for monitoring of relevant ESR1 variants by liquid biopsy

Breast cancer is the second most prevalent cancer-type globally. The current standard of care for hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2-) advanced breast cancer (ABC) is endocrine therapy (ET) plus cyclin-dependent kinase 4/6 inhibitor (CDK4/6i). Most ABC patients receiving ET...

L. Jackson, E. Barnett, Helen Halpin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.